These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16116073)

  • 1. The dynamics of cardiac fibrillation.
    Weiss JN; Qu Z; Chen PS; Lin SF; Karagueuzian HS; Hayashi H; Garfinkel A; Karma A
    Circulation; 2005 Aug; 112(8):1232-40. PubMed ID: 16116073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ionic currents and ventricular fibrillation dynamics].
    Moreno J; Warren M; Jalife J
    Rev Esp Cardiol; 2004 Jan; 57(1):69-79. PubMed ID: 14746720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of atrial remodeling and clinical relevance.
    Nattel S; Shiroshita-Takeshita A; Cardin S; Pelletier P
    Curr Opin Cardiol; 2005 Jan; 20(1):21-5. PubMed ID: 15596955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
    Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular fibrillation: new insights into mechanisms.
    Weiss JN; Chen PS; Wu TJ; Siegerman C; Garfinkel A
    Ann N Y Acad Sci; 2004 May; 1015():122-32. PubMed ID: 15201154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mother rotor anchoring in branching tissue with heterogeneous membrane properties.
    Wieser L; Nowak CN; Tilg B; Fischer G
    Biomed Tech (Berl); 2008 Feb; 53(1):25-35. PubMed ID: 18251708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel anti-arrhythmic agents for the treatment of atrial fibrillation.
    Wettwer E; Christ T; Dobrev D; Ravens U
    Curr Opin Pharmacol; 2007 Apr; 7(2):214-8. PubMed ID: 17303472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial proarrhythmia due to increased inward rectifier current (I(K1)) arising from KCNJ2 mutation--a simulation study.
    Kharche S; Garratt CJ; Boyett MR; Inada S; Holden AV; Hancox JC; Zhang H
    Prog Biophys Mol Biol; 2008; 98(2-3):186-97. PubMed ID: 19041665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term memory and restitution during ventricular fibrillation in human hearts: an in vivo study.
    Toal SC; Farid TA; Selvaraj R; Chauhan VS; Masse S; Ivanov J; Harris L; Downar E; Franz MR; Nanthakumar K
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):562-70. PubMed ID: 19843925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs that interact with cardiac electro-mechanics: old and new targets for treatment.
    Kirchhof P; Fortmüller L; Waldeyer C; Breithardt G; Fabritz L
    Prog Biophys Mol Biol; 2008; 97(2-3):497-512. PubMed ID: 18406454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics.
    Dobrev D; Nattel S
    J Cardiovasc Pharmacol; 2008 Oct; 52(4):293-9. PubMed ID: 18791467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrical remodeling in atrial fibrillation.
    Dobrev D
    Herz; 2006 Apr; 31(2):108-12; quiz 142-3. PubMed ID: 16738832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulated interactions between a Class III antiarrhythmic drug and a figure 8 reentry.
    Seigneuric RG; Chassé JL; Auger P; Bardou A
    Acta Biotheor; 2005; 53(4):265-75. PubMed ID: 16583269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer modeling of ventricular rhythm during atrial fibrillation and ventricular pacing.
    Lian J; Müssig D; Lang V
    IEEE Trans Biomed Eng; 2006 Aug; 53(8):1512-20. PubMed ID: 16916085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms and global dynamics of fibrillation: an integrative approach to the underlying basis of vortex-like reentry.
    Jalife J; Berenfeld O
    J Theor Biol; 2004 Oct; 230(4):475-87. PubMed ID: 15363670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole heart action potential duration restitution properties in cardiac patients: a combined clinical and modelling study.
    Nash MP; Bradley CP; Sutton PM; Clayton RH; Kallis P; Hayward MP; Paterson DJ; Taggart P
    Exp Physiol; 2006 Mar; 91(2):339-54. PubMed ID: 16452121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The short QT syndrome as a paradigm to understand the role of potassium channels in ventricular fibrillation.
    Cerrone M; Noujaim S; Jalife J
    J Intern Med; 2006 Jan; 259(1):24-38. PubMed ID: 16336511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organization of ventricular fibrillation in the human heart.
    Ten Tusscher KH; Hren R; Panfilov AV
    Circ Res; 2007 Jun; 100(12):e87-101. PubMed ID: 17540975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing ventricular fibrillation by flattening cardiac restitution.
    Garfinkel A; Kim YH; Voroshilovsky O; Qu Z; Kil JR; Lee MH; Karagueuzian HS; Weiss JN; Chen PS
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6061-6. PubMed ID: 10811880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From pulsus to pulseless: the saga of cardiac alternans.
    Weiss JN; Karma A; Shiferaw Y; Chen PS; Garfinkel A; Qu Z
    Circ Res; 2006 May; 98(10):1244-53. PubMed ID: 16728670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.